National Cancer Institute Research - Research Centers
Active
- Assistance listing
- 93.CA2
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Treasury account
-
- 75-0849-0-1-550
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Cancer Institute (a division of the National Institutes of Health, Department of Health and Human Services) funds interdisciplinary cancer research centers through Assistance Listing 93.CA2; the source does not identify a recent grant award date or open application deadline.
The program provides organizational and financial support for cancer research infrastructure and collaborative teams aimed at reducing cancer incidence, mortality, and morbidity. Funded activities center on establishing and operating research centers that integrate multiple scientific disciplines around cancer-focused research questions; the source does not detail representative recent awards or specify the types of research problems or cancer populations targeted.
The program evaluates applications through scientific peer review by subject-matter experts and the National Cancer Advisory Board. Evaluation criteria emphasize scientific merit and significance of proposed research, technical adequacy of experimental design, investigator competency, facility and resource adequacy, budget justification, and alignment with announced program objectives and NCI strategic priorities. Funding decisions rest on peer-review assessment, fund availability, and program priority relevance.
The source does not disclose the distribution of assistance types (Project Grants, Cooperative Agreements, or other forms), recent award volume, typical award magnitudes, or funding concentration among multiple agencies. It does not identify currently open grant opportunities or recent solicitation dates. Recipients must retain expenditure and financial records for three years following the final financial status report, and grants are subject to inspection and audit by HHS and other federal agencies consistent with 2 CFR Subpart F.
Without recent award data, recent opportunity postings, or award-size ranges in the source material, the current market activity and pursuit readiness for this program cannot be assessed from available information.
Objective and description
- Objective
To provide an organizational focus and stimulus for the highest quality cancer research that promotes interdisciplinary cancer research aimed at the ultimate goal of reducing cancer incidence, mortality and morbidity.
- Description
To provide an organizational focus and stimulus for the highest quality cancer research that promotes interdisciplinary cancer research aimed at the ultimate goal of reducing cancer incidence, mortality and morbidity.
How to apply
- Criteria for selecting proposals
The major elements in evaluating applications include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following will be considered in making funding decisions: 1) Scientific and technical merit of the proposed project as determined by scientific peer review; 2) Availability of funds; and 3) Relevance of the proposed project to program priorities.
- Award procedure
All applications are evaluated by scientific authorities for scientific and technical merit. Applications must also be reviewed by the National Cancer Advisory Board. All competitive applications compete for available funds on the basis of scientific and technical merit, program relevance, and program balance, consistent with NCI and NIH priorities and strategic plans.
- Appeals
From 120 to 180 days. A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH homepage https://grants.nih.gov/grants/guide/notice-files/not-od-11-064.html.
Quick answers
What is Assistance Listing 93.CA2?
Assistance Listing 93.CA2 is National Cancer Institute Research - Research Centers, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for National Cancer Institute Research - Research Centers?
Its CFDA number is 93.CA2: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program